Biocon, Bristol-Myers in deal for oral insulin drug

MUMBAI Fri Nov 16, 2012 10:49am IST

Related Topics

Stocks

   
A statue of Ganesh, the deity of prosperity, is carried in a taxi to a place of worship on the first day of the ten-day-long Ganesh Chaturthi festival in Mumbai August 29, 2014. REUTERS/Danish Siddiqui

Ganesh Chaturthi Festival

During Ganesh Chaturthi idols will be taken through the streets in a procession accompanied by dancing and singing, and will be immersed in a river or the sea in accordance with Hindu faith.  Slideshow 

MUMBAI (Reuters) - Biocon Ltd, India's top-listed biotechnology company, said it signed an agreement with Bristol-Myers Squibb Co under which the U.S. drugmaker will have the option to get the worldwide license to its oral insulin drug program.

Bristol Myers can choose to assume full responsibility for the development of the drug IN-105, if its mid-stage trial is successful.

Biocon, which has been looking to partner the drug for nearly two years, said it would receive a license fee as well as milestone payments and royalties based on commercial sales of the drug outside India. It will retain the rights to IN-105 in India.

Financial terms of the deal were not available.

Currently, there are no insulin tablets available and patients with diabetes who need insulin -- a naturally occurring protein that controls blood sugar -- must inject it.

Earlier this year, Pfizer scrapped a deal to sell injectable insulin products made by Biocon.

Biocon shares, which rose more than 4 percent in the previous session, were down 0.4 percent on Friday, while the broader market was up 0.3 percent.

(Reporting by Aradhana Aravindan; Editing by G.Ram Mohan)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Ebola Outbreak

HEALTH SHOWCASE

E-cigarettes

E-cigarettes

WHO urges stiff regulatory curbs on e-cigarettes.  Full Article 

Weighty Issues

Weighty Issues

More parents think their overweight child is 'about right'.  Full Article 

Cancer Drug

Cancer Drug

Pfizer to test Xalkori lung cancer drug with Merck immunotherapy.  Full Article 

Mental Health

Mental Health

Obama tells veterans better mental health care on the way.  Full Article 

Food Regulation

Food Regulation

Russian food safety regulator shuts fifth McDonald's restaurant.  Full Article 

Heinz Recall

Heinz Recall

Heinz recall brings food tracking issue to the fore in China.  Full Article 

Delaying Start

Delaying Start

Delay morning school start for teens: pediatricians.  Full Article 

Birth Control

Birth Control

U.S. moves to ensure birth control access at religious companies.  Full Article